Capital Expenditures for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current capital expenditures (TTM) is $5.07B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$5.07B
YoY change
+9.2%
5Y CAGR
+7.6%
Peak year (1998)
$4.94B
Cumulative capital expenditures
$98.03B
CapEx history chart for Johnson & Johnson (JNJ) from 1989 to 2025
CapEx history table for Johnson & Johnson (JNJ) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $4.83B | +9.2% | ||
| 2024 | $4.42B | -2.6% | ||
| 2023 | $4.54B | +13.3% | ||
| 2022 | $4.01B | +9.8% | ||
| 2021 | $3.65B | +9.1% | ||
| 2020 | $3.35B | -4.3% | ||
| 2019 | $3.50B | -4.7% | ||
| 2018 | $3.67B | +11.9% | ||
| 2017 | $3.28B | +1.6% | ||
| 2016 | $3.23B | -6.8% | ||
| 2015 | $3.46B | -6.8% | ||
| 2014 | $3.71B | +3.3% | ||
| 2013 | $3.60B | +22.5% | ||
| 2012 | $2.93B | +1.4% | ||
| 2011 | $2.89B | +21.4% | ||
| 2010 | $2.38B | +0.8% | ||
| 2009 | $2.37B | -22.9% | ||
| 2008 | $3.07B | -7.4% | ||
| 2007 | $3.31B | +20.9% | ||
| 2006 | $2.74B | +4.0% | ||
| 2005 | $2.63B | +21.0% | ||
| 2004 | $2.17B | -3.8% | ||
| 2003 | $2.26B | +7.8% | ||
| 2002 | $2.10B | +21.3% | ||
| 2001 | $1.73B | +5.2% | ||
| 2000 | $1.65B | -17.7% | ||
| 1999 | $2.00B | -59.5% | ||
| 1998 | $4.94B | +255.2% | ||
| 1997 | $1.39B | +1.3% | ||
| 1996 | $1.37B | +9.3% | ||
| 1995 | $1.26B | +34.0% | ||
| 1994 | $937.00M | -3.9% | ||
| 1993 | $975.00M | -11.6% | ||
| 1992 | $1.10B | +11.8% | ||
| 1991 | $987.00M | +18.9% | ||
| 1990 | $830.00M | +10.7% | ||
| 1989 | $750.00M | — |
CapEx values are taken from Johnson & Johnson's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Johnson & Johnson (JNJ) reported capital expenditures of $4.83B – grew 9.2% year-over-year.
Johnson & Johnson capital expenditures has recorded the values shown across consecutive periods, with a +7.6% compound annual growth rate over 2020–2025 (5 years).
Between 1998 and 2025, Johnson & Johnson capital expenditures edged down 2.2%, falling from $4.94B to $4.83B.
The highest annual capital expenditures of $4.94B was reported in 1998. The lowest in the available history was $750.00M in 1989.
Johnson & Johnson (JNJ) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of $3.22B.
Johnson & Johnson Capital Expenditures by Year
Johnson & Johnson Capital Expenditures 2025: $4.83B
Johnson & Johnson capital expenditures in 2025 was $4.83B, grew 9.2% from 2024.
Johnson & Johnson Capital Expenditures 2024: $4.42B
Johnson & Johnson capital expenditures in 2024 was $4.42B, edged down 2.6% below 2023.
Johnson & Johnson Capital Expenditures 2023: $4.54B
Johnson & Johnson capital expenditures in 2023 was $4.54B, grew 13.3% from 2022.
Johnson & Johnson Capital Expenditures 2022: $4.01B
Johnson & Johnson capital expenditures in 2022 was $4.01B, grew 9.8% from 2021.
Johnson & Johnson Capital Expenditures 2021: $3.65B
Johnson & Johnson capital expenditures in 2021 was $3.65B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — CapEx
Companies in the same sector as Johnson & Johnson, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $1.52B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's capital expenditures?
- Latest reported capital expenditures for Johnson & Johnson (JNJ) is $5.07B (period ending March 29, 2026).
How has Johnson & Johnson capital expenditures changed year-over-year?
- Johnson & Johnson (JNJ) capital expenditures changed +9.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson capital expenditures?
- Johnson & Johnson (JNJ) capital expenditures compound annual growth rate is +7.6% over the most recent 5 years available.
When did Johnson & Johnson capital expenditures hit its highest annual value?
- Johnson & Johnson capital expenditures reached its highest annual value of $4.94B in 1998.
What was Johnson & Johnson capital expenditures in 2024?
- Johnson & Johnson (JNJ) capital expenditures in 2024 was $4.42B.
What was Johnson & Johnson capital expenditures in 2025?
- Johnson & Johnson (JNJ) capital expenditures in 2025 was $4.83B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.